Wednesday - April 1, 2026
FDA Center for Veterinary Medicine Issues Warning Letter to Henan Lvyuan Pharmaceutical
April 01, 2026
WASHINGTON, April 1 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Henan Lvyuan Pharmaceutical Co. Ltd. from its Center for Veterinary Medicine:

* * *

Recipient: Mr. He Jingyin, General Manager, Henan Lvyuan Pharmaceutical Co. Ltd., Industrial Park, Qiliying Town, Xinxiang Xian Xinxiang Shi Henan Sheng, 453731, China, hnlyyy@hnlyy.com.cn

Issuing Office: Center for Veterinary Medicine, . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products